<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients may continue to have abnormal oesophageal acid exposure on <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of factors such as <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> length, <z:hpo ids='HP_0002036'>hiatal hernia</z:hpo> size and <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> on intra-oesophageal pH in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients has not been adequately studied </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To evaluate oesophageal acid exposure in a large <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> population on b.d. <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> therapy and determine clinical factors predicting normalization of intra-oesophageal pH on therapy </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients were studied using 24 h pH monitoring to evaluate intra-oesophageal acid suppression on b.d. dosing of <z:chebi fb="0" ids="8768">rabeprazole</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Forty-six <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients completed the study </plain></SENT>
<SENT sid="5" pm="."><plain>Median total percentage time pH &lt; 4 was 1.05% (range: 0-29.9%) in the entire group and respective values for upright and supine percentage time pH &lt; 4 were 1.15% and 0% </plain></SENT>
<SENT sid="6" pm="."><plain>However, 34 of the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients (73.9%) had a <z:mpath ids='MPATH_458'>normal</z:mpath> pH study (median total percentage time pH &lt; 4: 0.2%) and 12 patients (26.1%) had an abnormal result (median total percentage time pH &lt; 4: 9.3%) </plain></SENT>
<SENT sid="7" pm="."><plain>There were no significant differences between patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal 24 h pH result with respect to age, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> length, <z:hpo ids='HP_0002036'>hiatal hernia</z:hpo> size and presence of H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Approximately 25% of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients continue to have abnormal total intra-oesophageal pH profiles despite b.d. <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> therapy </plain></SENT>
<SENT sid="9" pm="."><plain>Factors such as age, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> length and <z:hpo ids='HP_0002036'>hiatal hernia</z:hpo> size cannot be used to predict persistent abnormal intra-oesophageal pH on <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> </plain></SENT>
</text></document>